| Filed On | Filing |
|---|---|
| 27 Oct 2026 | S-1 |
| 27 Oct 2026 |
8-K: Other Events
Date of Report (Date of earliest event reported): October 26, 2026 |
| 21 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
Agreement with VoxelDox Therapeutics, Inc. Creates a Clear Path to Future Value, Subject to Achievement of Development Milestones in the Planned Phase 1 Glioblastoma Trial |
| 13 Oct 2026 |
Form 4: Tardugno Michael H, Director
Received 7,800 shares as a grant or award ($8.42K) |
| 13 Oct 2026 |
Form 4: Lindborg Stacy, Director
Received 2,977 shares as a grant or award ($3.22K) |
| 13 Oct 2026 |
Form 4: Faller Douglas Vincent, Chief Medical Officer
Received 1,249 shares as a grant or award ($1.35K) |
| 29 Sep 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
Pursuant to Section 151 of the Delaware General Corporation Law |
| 28 Sep 2026 |
Form 4: Tardugno Michael H, Director
Received 7,169 shares as a grant or award ($10.1K) |
| 28 Sep 2026 |
Form 4: Lindborg Stacy, Director
Received 6,697 shares as a grant or award ($9.44K) |
| 28 Sep 2026 |
Form 4: Faller Douglas Vincent, Chief Medical Officer
Received 4,390 shares as a grant or award ($6.19K) |
| 15 Sep 2026 |
Form 4: Tardugno Michael H, Director
Received 5,824 shares as a grant or award ($8.56K) |
| 15 Sep 2026 |
Form 4: Lindborg Stacy, Director
Received 5,504 shares as a grant or award ($8.09K) |
| 15 Sep 2026 |
Form 4: Faller Douglas Vincent, Chief Medical Officer
Received 4,211 shares as a grant or award ($6.19K) |
| 01 Sep 2026 |
Form 4: Tardugno Michael H, Director
Received 7,371 shares as a grant or award ($11.8K) |
| 01 Sep 2026 |
Form 4: Lindborg Stacy, Director
Received 6,822 shares as a grant or award ($10.9K) |
| 01 Sep 2026 |
Form 4: Faller Douglas Vincent, Chief Medical Officer
Received 3,626 shares as a grant or award ($5.8K) |
| 01 Sep 2026 |
Form 4: Eylward Susan, General Counsel and Corp Sec
Received 2,525 shares as a grant or award ($4.04K) · Sold 2,525 shares ($3.95K) |
| 17 Aug 2026 |
Form 4: Lindborg Stacy, Director
Received 6,615 shares as a grant or award ($10.9K) |
| 17 Aug 2026 |
Form 4: Faller Douglas Vincent, Chief Medical Officer
Received 3,516 shares as a grant or award ($5.8K) |
| 17 Aug 2026 |
Form 4: Tardugno Michael H, Director
Received 7,147 shares as a grant or award ($11.8K) |
Loading...